The FDA announced the recall of Solodyn yesterday, a drug used to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.

The recalled lot (numbers B080037 and B080038) contained Azasan, or azathioprine tablets instead of Solodyn tablets. Azasan is an immunosuppressive agent used in transplant patients to prevent kidney rejection. It is also used to treat patients with rheumatoid arthritis.
This switch could seriously, adversely affect patients, and could lead to injury or death. Side effects of Azasan include:
·         Myelosuppression
·         Infection
·         Bleeding
·         Chills
·         Nausea
·         Vomiting
·         Diarrhea
·         Joint and muscle pain
The recall is limited to the lots mentioned above. If you think your Solodyn might contain Azasan, contact your health care provider immediately. Health care professionals are urged to check inventory and contact manufacturers if they have the referenced lot numbers.
Share this entry:
 These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • Technorati
  • del.icio.us
  • StumbleUpon
  • Reddit
  • Fark
  • Furl
  • Twitter